In a recent open Letter to Shareholders, Cord Blood America, Inc.’s (CBAI.OB) CEO Matthew Schissler outlined the Company’s accomplishments.
Mr. Schissler noter, “I am 100% confident in the ability of CBAI to continue to grow, thrive and be a leader in the stem cell storage industry. I am also extremely excited about the current and future prospects of the organization, and have never felt better about the direction of our Company.”
In 2007, we promised shareholders that we would continue to be aggressive in seeking accretive acquisitions (there are two in early discussion now) that could add valuable assets to our customer base.
CBAI’s recent acquisitions are well documented. We are also growing organically in a more focused, less expensive way, by using a sales model tied to the health insurance provider channels.
We have assured shareholders that we are making every effort to become cash flow positive through such strategies as accretive assets, by reducing costs, and by focusing on strategic growth.
Let us hear your thoughts below: